BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35748699)

  • 21. Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis.
    Al-Jameil N; Hassan AA; Buhairan A; Hassanato R; Isac SR; Al-Otaiby M; Al-Maarik B; Al-Ajeyan I
    Medicine (Baltimore); 2017 Feb; 96(6):e6071. PubMed ID: 28178162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients.
    Sark AD; Fromme M; Olejnicka B; Welte T; Strnad P; Janciauskiene S; Stolk J
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
    Schmid ST; Koepke J; Dresel M; Hattesohl A; Frenzel E; Perez J; Lomas DA; Miranda E; Greulich T; Noeske S; Wencker M; Teschler H; Vogelmeier C; Janciauskiene S; Koczulla AR
    Int J Chron Obstruct Pulmon Dis; 2012; 7():687-96. PubMed ID: 23055718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1-antitrypsin.
    Baligar P; Kochat V; Arindkar SK; Equbal Z; Mukherjee S; Patel S; Nagarajan P; Mohanty S; Teckman JH; Mukhopadhyay A
    Hepatology; 2017 Apr; 65(4):1319-1335. PubMed ID: 28056498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
    Karatas E; Raymond AA; Leon C; Dupuy JW; Di-Tommaso S; Senant N; Collardeau-Frachon S; Ruiz M; Lachaux A; Saltel F; Bouchecareilh M
    JHEP Rep; 2021 Aug; 3(4):100297. PubMed ID: 34151245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Ruiz M; Lacaille F; Schrader C; Pons M; Socha P; Krag A; Sturm E; Bouchecareilh M; Strnad P
    Semin Liver Dis; 2023 Aug; 43(3):258-266. PubMed ID: 37402396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
    Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
    Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I; Miravitlles M
    BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L; Stolk J; Frants RR; Veldhuisen B
    Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease Status at Diagnosis in Danish Children with α 1 -antitrypsin Deficiency.
    Winther CL; Nyrann S; Nielsen RG; Duno M; Johansen KB; Helt TW; Brix Christensen V
    J Pediatr Gastroenterol Nutr; 2022 Nov; 75(5):629-634. PubMed ID: 36070551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels and genotype distribution of α1-antitrypsin in the general population.
    Ferrarotti I; Thun GA; Zorzetto M; Ottaviani S; Imboden M; Schindler C; von Eckardstein A; Rohrer L; Rochat T; Russi EW; Probst-Hensch NM; Luisetti M
    Thorax; 2012 Aug; 67(8):669-74. PubMed ID: 22426792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization.
    Fra AM; Gooptu B; Ferrarotti I; Miranda E; Scabini R; Ronzoni R; Benini F; Corda L; Medicina D; Luisetti M; Schiaffonati L
    PLoS One; 2012; 7(6):e38405. PubMed ID: 22723858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatic involvement in hereditary alpha-1-antitrypsin deficiency].
    Lachaux A; Dumortier J
    Rev Mal Respir; 2014 Apr; 31(4):357-64. PubMed ID: 24750955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults.
    Brantly ML; Spencer LT; Humphries M; Conlon TJ; Spencer CT; Poirier A; Garlington W; Baker D; Song S; Berns KI; Muzyczka N; Snyder RO; Byrne BJ; Flotte TR
    Hum Gene Ther; 2006 Dec; 17(12):1177-86. PubMed ID: 17115945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study.
    Kim RG; Nguyen P; Bettencourt R; Dulai PS; Haufe W; Hooker J; Minocha J; Valasek MA; Aryafar H; Brenner DA; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2016 Aug; 44(3):287-99. PubMed ID: 27279429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.
    Fromme M; Schneider CV; Pereira V; Hamesch K; Pons M; Reichert MC; Benini F; Ellis P; H Thorhauge K; Mandorfer M; Burbaum B; Woditsch V; Chorostowska-Wynimko J; Verbeek J; Nevens F; Genesca J; Miravitlles M; Nuñez A; Schaefer B; Zoller H; Janciauskiene S; Abreu N; Jasmins L; Gaspar R; Liberal R; Macedo G; Mahadeva R; Gomes C; Schneider KM; Trauner M; Krag A; Gooptu B; Thorburn D; Marshall A; Hurst JR; Lomas DA; Lammert F; Gaisa NT; Clark V; Griffiths W; Trautwein C; Turner AM; McElvaney NG; Strnad P
    Gut; 2022 Feb; 71(2):415-423. PubMed ID: 33632708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic value of alpha 1-antitrypsin globules in liver cells as a morphological marker of alpha 1-antitrypsin deficiency.
    Clausen PP; Lindskov J; Gad I; Kreutzfeldt M; Orholm M; Reinicke V; Larsen HR; Strøm P
    Liver; 1984 Dec; 4(6):353-9. PubMed ID: 6394943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.
    Guo S; Booten SL; Aghajan M; Hung G; Zhao C; Blomenkamp K; Gattis D; Watt A; Freier SM; Teckman JH; McCaleb ML; Monia BP
    J Clin Invest; 2014 Jan; 124(1):251-61. PubMed ID: 24355919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha1-Antitrypsin deficiency: best clinical practice.
    Kalsheker NA
    J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.